Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib

E-ISSN： 1365-2168|102|8|965-971

ISSN： 0007-1323

Source： BRITISH JOURNAL OF SURGERY, Vol.102, Iss.8, 2015-07, pp. : 965-971

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib in Gastrointestinal Stromal Tumor: Does Treatment Duration Matter?

Oncology, Vol. 77, Iss. 3-4, 2009-09 ,pp. : 157-161

Karger

Access to resources Recommend Favorite

Critical Update and Emerging Trends in Imatinib Treatment for Gastrointestinal Stromal Tumor

Reviews on Recent Clinical Trials, Vol. 2, Iss. 1, 2007-01 ,pp. : 43-48

Bentham Science Publishers

Access to resources Recommend Favorite

Genotype and risk of tumour rupture in gastrointestinal stromal tumour

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 2, 2018-01 ,pp. : e169-e175

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imatinib‐induced agranulocytosis in patients with gastrointestinal stromal tumors

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 8, 2015-08 ,pp. : 920-925

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ten Years of Treatment with 400 mg Imatinib per Day in a Case of Advanced Gastrointestinal Stromal Tumor

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-10 ,pp. : 505-511

Karger

Access to resources Recommend Favorite